Literature DB >> 8082496

Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry.

G A Neil1, R W Summers, B A Cheyne, C Carpenter, W L Huang, T J Waldschmidt.   

Abstract

In order to better define changes in the relative proportion of peripheral blood T-lymphocyte subpopulations in patients with inflammatory diseases of the bowel, we performed simultaneous three-color fluorescence-activated cytometric (FACS) analysis using fluorophore-conjugated monoclonal antibodies with specificity for CD4, CD8, Leu 8, and CD45RA on 22 normal control subjects, 28 patients with Crohn's disease (CD), 15 patients with ulcerative colitis (UC), and 11 patients with intestinal inflammation secondary to etiologies other than inflammatory bowel disease (NIBD). This staining combination allowed enumeration of distinct T-cell subpopulations as follows: virgin CD4+, recall antigen helper T cells, nonspecific B-cell helper T cell, virgin CD8+, cytotoxic effector and suppressor effector and recall antigen cytotoxic T cells based on a synthesis of published functional analyses. No differences in the proportion of CD4+ or CD8+ cells or in the CD4+/CD8+ ratios were evident when UC and NIBD patients were compared to normal subjects. A significant reduction in the proportion of CD4+ cells and an increase in CD8+ cells was observed, however, in the CD group. When two-color analysis was performed, several significant differences in the proportions of circulating lymphocytes were seen. Specifically, these included significant increases in the number of CD4+, Leu 8- (P < 0.01) cells in all disease groups and an increase in CD4+, CD45RA+ cells in the NIBD group. Conversely, significant decreases in the proportions of CD8+, Leu 8+ (P < 0.01) cells were evident in the Crohn's disease group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082496     DOI: 10.1007/bf02088123

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. I. Differential helper cell requirement for the generation of cytotoxic effector cells from CD8+ precursor subpopulations.

Authors:  H Z Bass; N Yamashita; L T Clement
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

Review 2.  Functional analysis of human T cell subsets defined by CD45 isoform expression.

Authors:  P C Beverley
Journal:  Semin Immunol       Date:  1992-02       Impact factor: 11.130

3.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

Review 4.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

5.  Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease.

Authors:  M Senju; F Hulstaert; J Lowder; D P Jewell
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

6.  A study of the immunologic aspects of chronic ulcerative colitis and transmural colitis.

Authors:  S D Deodhar; W M Michener; R G Farmer
Journal:  Am J Clin Pathol       Date:  1969-05       Impact factor: 2.493

7.  Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.

Authors:  S Meyers; D B Sacher; R N Taub; H D Janowitz
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

8.  Human antigen-specific memory T cells express the homing receptor (LAM-1) necessary for lymphocyte recirculation.

Authors:  T F Tedder; T Matsuyama; D Rothstein; S F Schlossman; C Morimoto
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

9.  Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.

Authors:  S P James; L M Neckers; A S Graeff; J Cossman; C M Balch; W Strober
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

10.  Phenotypic identification of suppressor-effector, suppressor-amplifier and suppressor-inducer T cells of B cell differentiation in man.

Authors:  G S Kansas; E G Engleman
Journal:  Eur J Immunol       Date:  1987-04       Impact factor: 5.532

View more
  7 in total

Review 1.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 2.  Inflammaging decreases adaptive and innate immune responses in mice and humans.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Biogerontology       Date:  2015-04-29       Impact factor: 4.277

3.  Regulation of NKG2D+CD8+ T-cell-mediated antitumor immune surveillance: Identification of a novel CD28 activation-mediated, STAT3 phosphorylation-dependent mechanism.

Authors:  Jiemiao Hu; Izhar S Batth; Xueqing Xia; Shulin Li
Journal:  Oncoimmunology       Date:  2016-11-01       Impact factor: 8.110

4.  Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Petra Adamkova; Petra Hradicka; Helena Kupcova Skalnikova; Veronika Cizkova; Petr Vodicka; Silvia Farkasova Iannaccone; Monika Kassayova; Sona Gancarcikova; Vlasta Demeckova
Journal:  Vet Sci       Date:  2022-05-16

5.  Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3.

Authors:  Stanley T Parish; Jennifer E Wu; Rita B Effros
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

6.  Pathogenesis of type II avian adenovirus infection in turkeys: in vivo immune cell tropism and tissue distribution of the virus.

Authors:  M Suresh; J M Sharma
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Treg activation defect in type 1 diabetes: correction with TNFR2 agonism.

Authors:  Yoshiaki Okubo; Heather Torrey; John Butterworth; Hui Zheng; Denise L Faustman
Journal:  Clin Transl Immunology       Date:  2016-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.